Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,233
Total Claims
$1.9M
Drug Cost
970
Beneficiaries
$1,918
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+63%
Opioid rate vs peers
4.2% vs 2.6% avg
+80%
Cost per patient vs peers
$1,918 vs $1,068 avg
+113%
Brand preference vs peers
19.2% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.2%
Opioid Rate
848
Opioid Claims
$25K
Opioid Cost
13.1%
Long-Acting Rate
Brand vs Generic
Brand: 3,864 claims · $1.4M
Generic: 16,291 claims · $414K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 452 | $152K |
| Interferon Beta-1a/Albumin | 13 | $136K |
| Sitagliptin Phosphate | 264 | $89K |
| Dulaglutide | 72 | $74K |
| Pimavanserin Tartrate | 16 | $63K |
| Empagliflozin | 152 | $60K |
| Rivaroxaban | 135 | $45K |
| Dextromethorphan Hbr/Quinidine | 53 | $38K |
| Insulin Glargine,hum.Rec.Anlog | 176 | $29K |
| Semaglutide | 27 | $29K |
| Rifaximin | 16 | $24K |
| Dapagliflozin Propanediol | 59 | $23K |
| Semaglutide | 22 | $22K |
| Insulin Detemir | 97 | $22K |
| Linagliptin | 51 | $21K |
Prescribing Profile
Patient Profile
76
Avg Age
65%
Female
2.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data